General Information
Revision date
2002-06-07
Product name
Nimbex Injection
Product Synonyms
Cistatracurium Injection
CAS No.
96946-42-8
Manufacturer Name
Abbott Laboratories Hospital Products Division
Icons in SDS
Company Information
company name
Abbott Laboratories Hospital Products Division
Section 2
SECTION 2: Hazards identification
Emergency Overview: Liquid. Odorless. Non-flammable. Toxic by ingestion.
Principle Routes of Exposure
Oral: Unlikely (intact container) Dermal: Unlikely (intact container) Inhalation: Unlikely (intact container) Hazard Information: Ingestion Rating: Toxic Skin Absorption Rating: None Inhalation Rating: Not determined. Corrosiveness Rating: None Skin Contact Rating: None Skin Sensitization Rating: None Eye Contact Rating: Not determined. Target Organs: Nervous System •Eyes •Cardiovascular System •Respiratory System • Carcinogenicity Rating: Ingredients Percent OSHA: NTP: IARC: ACGIH: Cisatracurium 1 Not Listed Besylate 96946-42-8
NFPA Ratings
Health: 2 Signs and Symptoms: Clinical data suggests the following: decreased blood pressure, cardiac changes, flushing, breathing difficulty, rash, respiratory distress.
Medical Conditions Generally Aggravated by Exposure
Data suggest any preexisting ailments in the following organs: eyes, central nervous system.
